Addressing the impact of recent conflicts on the nation’s healthcare system, Zafarkandi revealed that 73 hospitals and approximately 300 ambulances were damaged in the recent U.S.- Israeli-imposed war on Iran.
He also noted that several pharmaceutical manufacturing facilities and medical infrastructure were damaged.
“Despite these intense pressures, the strength, experience, and long-standing foundation of our health system have allowed medical services to continue uninterrupted,” Zafarkandi stated. He urged that these capabilities be presented as models for the next generation of healthcare professionals and students.
The Minister called for a holistic view of the pharmaceutical sector, emphasizing that discussions must integrate drug manufacturing, pharmaceutical diplomacy, startups, and international trade. “To ensure that ‘Iran remains healthy,’ we must view the pharmaceutical industry and the healthcare system as an interconnected whole, rather than focusing solely on the economics of medicine,” he added.
Zafarkandi also highlighted the urgent need for better public awareness regarding drug consumption. He drew attention to the global crisis of antimicrobial resistance (AMR), noting that nearly 5 million people die annually worldwide due to AMR. He stressed that serious action is required to improve drug consumption patterns and combat resistance.
Neda Sajjadi - Hossein Vaez
